A comparative study between oral itraconazole and terbinafine in tinea infectio
Phase 3
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/10/058844
- Lead Sponsor
- Mahatma Gandhi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
all KOH positive tinea cases of age between 18 and 65 years
-body surface area involvement more than 5%
-patient giving written informed consent for study
Exclusion Criteria
-pregnant and lactating women
-patient with preexisting renal, hepatic and cardiac disease
-patient with onychomycosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method By assessing dercrease in erythema, scaling, vesiculation, fissuring, maceration, exudationTimepoint: baseline, 3 weeks, 6 weeks and 12 weeks
- Secondary Outcome Measures
Name Time Method to know about relapseTimepoint: at 3 months follow up